Can Tumor Mutational Burden Guide Treatment in Metastatic Breast Cancer?

(MedPage Today) -- A study presented at the San Antonio Breast Cancer Symposium examined whether tumor mutational burden (TMB) was associated with outcomes in hormone receptor-positive, HER2-negative metastatic breast cancer patients treated with...